Foca Gene 4
4 · Getty Images Holdings, Inc. · Filed Oct 5, 2023
Insider Transaction Report
Form 4
Foca Gene
Chief Marketing Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-10-03$2.74/sh−50,000$137,000→ 1,029,047 totalExercise: $2.74Exp: 2029-04-10→ Class A Common Stock (50,000 underlying) - Exercise/Conversion
Class A Common Stock
2023-10-03$2.74/sh+50,000$137,000→ 385,956 total - Sale
Class A Common Stock
2023-10-03$5.60/sh−50,000$280,000→ 335,956 total
Footnotes (3)
- [F1]Transaction made pursuant to a Rule 10b5-1(c) plan adopted on March 15, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.50 to $6.09. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Stock options are fully vested and exercisable.